Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
Introduction to Drug Utilization Research
(2003; 49 pages) View the PDF document
Table of Contents
View the documentPreface: Drug utilization research - the early work
Open this folder and view contentsChapter 1: What is drug utilization research and why is it needed?
Open this folder and view contentsChapter 2: Types of drug use information
Open this folder and view contentsChapter 3: Sources of data on drug utilization
Open this folder and view contentsChapter 4: Economic aspects of drug use (pharmacoeconomy)
Open this folder and view contentsChapter 5: Drug classification systems
Open this folder and view contentsChapter 6: Drug utilization metrics and their applications
View the documentChapter 7: Solutions to the exercises
View the documentAcknowledgements
 

Introduction to Drug Utilization Research

2003

World Health Organization

WHO International Working Group for Drug Statistics Methodology

WHO Collaborating Centre for Drug Statistics Methodology

WHO Collaborating Centre for Drug Utilization Research and Clinical

Pharmacological Services

WHO Library Cataloguing-in-Publication Data

Introduction to drug utilization research / WHO International Working Group for Drug Statistics Methodology,WHO Collaborating Centre for Drug Statistics Methodology, WHO Collaborating Centre for Drug Utilization Research and Clinical Pharmacological Services.

1. Drug utilization 2. Research 3. Manuals I.WHO International Working Group for Drug Statistics Methodology II.WHO Collaborating Centre for Drug Statistics Methodology III.WHO Collaborating Centre for Drug Utilization Research and Clinical Pharmacological Services

ISBN 92 4 156234 X

(NLM classification:WB 330)

© World Health Organization 2003

All rights reserved. Publications of the World Health Organization can be obtained from Marketing and Dissemination,World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to Publications, at the above address (fax: +41 22 791 4806; email: permissions@who.int).

The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

The mention of specific companies or of certain manufacturers’products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted,the names of proprietary products are distinguished by initial capital letters.

The World Health Organization does not warrant that the information contained in this publication is complete and correct and shall not be liable for any damages incurred as a result of its use.

Printed in Oslo, Norway, 2003

 

to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: August 29, 2014